Literature DB >> 11786968

Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis.

Arndt Vogel1, Christian P Strassburg, Michael P Manns.   

Abstract

Autoimmune hepatitis (AIH) and primary biliary cirrhosis (PBC) are immune-mediated chronic inflammatory diseases of the liver of unknown etiology. Genetic factors appear to be involved in the pathogenesis of both diseases. 1,25-Dihydroxyvitamin D(3) has been implicated as an immunomodulator, which acts through its own receptor (VDR). Polymorphisms of the VDR have been linked to a variety of autoimmune diseases. In this study VDR polymorphisms were analyzed in 123 patients with AIH, 74 patients with PBC, and 214 controls. VDR polymorphisms were assessed by BsmI, TaqI, ApaI, and Fok endonuclease digestion after specific polymerase chain reaction (PCR) amplification. We found a significant association between the BsmI polymorphisms in PBC patients in comparison with controls (chi(2) = 9.49, P =.009). Furthermore we detected a significant association of the Fok polymorphims in AIH patients in comparison to controls (chi(2) = 9.71, P =.008) indicating a genetic link of VDR polymorphisms to autoimmune liver diseases such as PBC and AIH in German patients. These findings contribute to the knowledge of the complex events determining immunologic tolerance in the liver. Further studies are needed to elucidate the mechanisms by which the vitamin D receptor contributes to the development of autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11786968     DOI: 10.1053/jhep.2002.30084

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  78 in total

Review 1.  Does vitamin D affect risk of developing autoimmune disease?: a systematic review.

Authors:  Martin A Kriegel; JoAnn E Manson; Karen H Costenbader
Journal:  Semin Arthritis Rheum       Date:  2010-11-02       Impact factor: 5.532

Review 2.  Role of vitamins in gastrointestinal diseases.

Authors:  Omar A Masri; Jean M Chalhoub; Ala I Sharara
Journal:  World J Gastroenterol       Date:  2015-05-07       Impact factor: 5.742

Review 3.  Targeting Hepatic Fibrosis in Autoimmune Hepatitis.

Authors:  Aldo J Montano-Loza; Ragesh B Thandassery; Albert J Czaja
Journal:  Dig Dis Sci       Date:  2016-07-19       Impact factor: 3.199

Review 4.  Emerging opportunities for site-specific molecular and cellular interventions in autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2010-01-27       Impact factor: 3.199

5.  Lack of association between vitamin D receptor gene ApaI, BsmI, and TaqI polymorphisms and primary biliary cirrhosis risk: a meta-analysis.

Authors:  Cuiju Mo; Yu Lu; Yan Deng; Jian Wang; Li Xie; Taijie Li; Yu He; Xue Qin; Shan Li
Journal:  Tumour Biol       Date:  2014-02-14

Review 6.  Cell mediators of autoimmune hepatitis and their therapeutic implications.

Authors:  Aldo J Montano-Loza; Albert J Czaja
Journal:  Dig Dis Sci       Date:  2014-12-09       Impact factor: 3.199

7.  Polymorphisms in the vitamin D receptor gene and risk of autoimmune thyroid diseases: a meta-analysis.

Authors:  Ming Feng; Hua Li; Su-Fang Chen; Wei-Fang Li; Fang-Bin Zhang
Journal:  Endocrine       Date:  2012-10-12       Impact factor: 3.633

8.  Genomic variants associated with primary biliary cirrhosis.

Authors:  Carlo Selmi; Natalie J Torok; Andrea Affronti; M Eric Gershwin
Journal:  Genome Med       Date:  2010-01-26       Impact factor: 11.117

Review 9.  Current understanding of osteoporosis associated with liver disease.

Authors:  Inaam A Nakchbandi; Schalk W van der Merwe
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-11       Impact factor: 46.802

10.  Association of vitamin D binding protein polymorphism with long-term kidney allograft survival in Hispanic kidney transplant recipients.

Authors:  Don Vu; Prashant Sakharkar; Eglis Tellez-Corrales; Tariq Shah; Ian Hutchinson; David I Min
Journal:  Mol Biol Rep       Date:  2012-10-17       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.